10-K Filing

AGILON HEALTH, INC. CIK: 1831097 FY 2022

Filing Information

Form Type	10-K
Accession Number	`0000950170-23-005541`
Period End Date	20221231
Filing Date	20230301
Fiscal Year	2022
Fiscal Period	FY
XBRL Instance	agl-20221231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 68 Income Statement 82 Cash Flow Statement 120 Stockholders Equity 34 Comprehensive Income 15

Balance Sheet 68 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.04B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$497.07M	USD	Point-in-time
Restricted cash and equivalents	`RestrictedCashEquivalentsCurrent`	$14.78M	USD	Point-in-time
Restricted cash and equivalents	`RestrictedCashEquivalentsCurrent`	$10.61M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	-	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$411.90M	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$293.41M	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$497.57M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$34.12M	USD	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$18.97M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	2.00B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.37B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.45B	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	2.00B	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	400.10M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	412.38M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$20.05M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$9.16M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	400.10M	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$55.40M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$67.68M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	412.38M	shares	Point-in-time
Assets	`Assets`	$1.70B	USD	Point-in-time
Assets	`Assets`	$1.59B	USD	Point-in-time
Goodwill	`Goodwill`	$41.54M	USD	Point-in-time
Goodwill	`Goodwill`	$41.54M	USD	Point-in-time
Liabilities	`Liabilities`	$494.66M	USD	Point-in-time
Liabilities	`Liabilities`	$656.86M	USD	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$112.96M	USD	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$116.92M	USD	Point-in-time
Total assets	`Assets`	$1.70B	USD	Point-in-time
Total assets	`Assets`	$1.59B	USD	Point-in-time
Medical claims and related payables	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$239.01M	USD	Point-in-time
Medical claims and related payables	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$346.73M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$112.95M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$183.36M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$5.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$5.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$535.09M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$356.96M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$43.40M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$38.48M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$83.29M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$94.30M	USD	Point-in-time
Total liabilities	`Liabilities`	$494.66M	USD	Point-in-time
Total liabilities	`Liabilities`	$656.86M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value: 2,000,000 shares authorized; 412,385 and 400,095 shares issued and outstanding, respectively	`CommonStockValue`	$4.00M	USD	Point-in-time
Common stock, $0.01 par value: 2,000,000 shares authorized; 412,385 and 400,095 shares issued and outstanding, respectively	`CommonStockValue`	$4.12M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.11B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.05B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-957.68M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.06B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	-	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.56M	USD	Point-in-time
Total agilon health, inc. stockholders' equity (deficit)	`StockholdersEquity`	$1.09B	USD	Point-in-time
Total agilon health, inc. stockholders' equity (deficit)	`StockholdersEquity`	$1.04B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$-611.00K	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$-300.00K	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.04B	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-232.03M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$1.59B	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$1.70B	USD	Point-in-time

Income Statement 82 line items

Line Item	Tag	Value	Unit	Period
General And Administrative Including Non Cash Stock-based Compensation Expense	`AllocatedShareBasedCompensationExpense`	$292.39M	USD	Annual
General And Administrative Including Non Cash Stock-based Compensation Expense	`AllocatedShareBasedCompensationExpense`	$2.60M	USD	Point-in-time
General And Administrative Including Non Cash Stock-based Compensation Expense	`AllocatedShareBasedCompensationExpense`	$28.38M	USD	Annual
General And Administrative Including Non Cash Stock-based Compensation Expense	`AllocatedShareBasedCompensationExpense`	$6.47M	USD	Annual
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.71B	USD	Annual
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.83B	USD	Annual
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.22B	USD	Annual
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$1.65B	USD	Annual
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$1.02B	USD	Annual
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$2.40B	USD	Annual
Other medical expenses	`OtherMedicalExpenses`	$109.49M	USD	Annual
Other medical expenses	`OtherMedicalExpenses`	$196.13M	USD	Annual
Other medical expenses	`OtherMedicalExpenses`	$102.31M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$137.29M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$455.82M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$218.94M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$13.77M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$14.54M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$13.53M	USD	Annual
Total expenses	`OperatingExpenses`	$1.28B	USD	Annual
Total expenses	`OperatingExpenses`	$2.83B	USD	Annual
Total expenses	`OperatingExpenses`	$2.23B	USD	Annual
Income (loss) from operations	`OperatingIncomeLoss`	$-56.67M	USD	Annual
Income (loss) from operations	`OperatingIncomeLoss`	$-120.43M	USD	Annual
Income (loss) from operations	`OperatingIncomeLoss`	$-393.95M	USD	Annual
Other income (expense), net	`NonoperatingIncomeExpense`	$24.73M	USD	Annual
Other income (expense), net	`NonoperatingIncomeExpense`	$-4.50M	USD	Annual
Other income (expense), net	`NonoperatingIncomeExpense`	$2.46M	USD	Annual
Gain (loss) on lease terminations	`GainLossOnTerminationOfLease`	-	USD	Annual
Gain (loss) on lease terminations	`GainLossOnTerminationOfLease`	-	USD	Annual
Gain (loss) on lease terminations	`GainLossOnTerminationOfLease`	$-5.46M	USD	Annual
Interest expense	`InterestExpense`	$6.15M	USD	Annual
Interest expense	`InterestExpense`	$4.53M	USD	Annual
Interest expense	`InterestExpense`	$8.13M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-404.60M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-62.34M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-105.69M	USD	Annual
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$886.00K	USD	Annual
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$865.00K	USD	Annual
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$1.64M	USD	Annual
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-405.48M	USD	Annual
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-63.21M	USD	Annual
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-107.33M	USD	Annual
Income (loss) before impairments, gain (loss) on sales and income taxes	`DiscontinuedOperationsIncomeLossBeforeImpairmentsGainLossOnSalesAndIncomeTaxes`	$491.00K	USD	Annual
Income (loss) before impairments, gain (loss) on sales and income taxes	`DiscontinuedOperationsIncomeLossBeforeImpairmentsGainLossOnSalesAndIncomeTaxes`	$-20.05M	USD	Annual
Income (loss) before impairments, gain (loss) on sales and income taxes	`DiscontinuedOperationsIncomeLossBeforeImpairmentsGainLossOnSalesAndIncomeTaxes`	$-3.46M	USD	Annual
Gain (loss) on sales of assets, net	`DiscontinuedOperationGainLossOnSaleOfAssetsNet`	-	USD	Annual
Gain (loss) on sales of assets, net	`DiscontinuedOperationGainLossOnSaleOfAssetsNet`	$473.00K	USD	Annual
Gain (loss) on sales of assets, net	`DiscontinuedOperationGainLossOnSaleOfAssetsNet`	$20.40M	USD	Annual
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$-2.80M	USD	Annual
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$26.00K	USD	Annual
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$-1.69M	USD	Annual
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.30M	USD	Annual
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$3.16M	USD	Annual
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$465.00K	USD	Annual
Net income (loss)	`ProfitLoss`	$-406.79M	USD	Annual
Net income (loss)	`ProfitLoss`	$-106.86M	USD	Annual
Net income (loss)	`ProfitLoss`	$-60.05M	USD	Annual
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$-300.00K	USD	Annual
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	Annual
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$-311.00K	USD	Annual
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-60.05M	USD	Annual
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-406.49M	USD	Annual
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-106.55M	USD	Annual
Net income (loss) per common share from continuing operations basic and diluted	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.20	USD	Annual
Net income (loss) per common share from continuing operations basic and diluted	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.09	USD	Annual
Net income (loss) per common share from continuing operations basic and diluted	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.26	USD	Annual
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	-	USD	Annual
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	-	USD	Annual
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	$0.01	USD	Annual
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.26	USD	Annual
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-1.09	USD	Annual
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.20	USD	Annual
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	-	USD	Annual
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	$0.01	USD	Annual
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	-	USD	Annual
Weighted Average Number of Shares Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	323.46M	shares	Annual
Weighted Average Number of Shares Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	372.93M	shares	Annual
Weighted Average Number of Shares Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	408.15M	shares	Annual
Weighted Average Number of Shares Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	372.93M	shares	Annual
Weighted Average Number of Shares Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	323.46M	shares	Annual
Weighted Average Number of Shares Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	408.15M	shares	Annual

Cash Flow Statement 120 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-406.79M	USD	Annual
Net income (loss)	`ProfitLoss`	$-106.86M	USD	Annual
Net income (loss)	`ProfitLoss`	$-60.05M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$13.77M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$14.67M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$14.10M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$6.69M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$28.38M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$292.39M	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-1.59M	USD	Annual
Loss (income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$514.00K	USD	Annual
Loss (income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$10.72M	USD	Annual
Loss (income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-6.77M	USD	Annual
Deferred income taxes and uncertain tax positions	`DeferredIncomeTaxesAndUncertainTaxPositions`	$3.23M	USD	Annual
Deferred income taxes and uncertain tax positions	`DeferredIncomeTaxesAndUncertainTaxPositions`	$-532.00K	USD	Annual
Deferred income taxes and uncertain tax positions	`DeferredIncomeTaxesAndUncertainTaxPositions`	$2.81M	USD	Annual
Release of indemnification assets	`FDICIndemnificationAssetNetWriteOffs`	$-1.71M	USD	Annual
Release of indemnification assets	`FDICIndemnificationAssetNetWriteOffs`	$-3.48M	USD	Annual
Release of indemnification assets	`FDICIndemnificationAssetNetWriteOffs`	$-553.00K	USD	Annual
(Gain) loss on sale of assets, net	`GainLossOnDispositionOfAssets1`	$-20.40M	USD	Annual
(Gain) loss on sale of assets, net	`GainLossOnDispositionOfAssets1`	-	USD	Annual
(Gain) loss on sale of assets, net	`GainLossOnDispositionOfAssets1`	$-473.00K	USD	Annual
Distributions of earnings from equity method investments	`DistributionsOfEarningsFromEquityMethodInvestments`	-	USD	Annual
Distributions of earnings from equity method investments	`DistributionsOfEarningsFromEquityMethodInvestments`	$-174.00K	USD	Annual
Distributions of earnings from equity method investments	`DistributionsOfEarningsFromEquityMethodInvestments`	-	USD	Annual
Other non-cash items	`OtherNoncashIncomeExpense`	$162.00K	USD	Annual
Other non-cash items	`OtherNoncashIncomeExpense`	$-2.97M	USD	Annual
Other non-cash items	`OtherNoncashIncomeExpense`	$-58.00K	USD	Annual
Receivables, net	`IncreaseDecreaseInReceivables`	$149.04M	USD	Annual
Receivables, net	`IncreaseDecreaseInReceivables`	$204.17M	USD	Annual
Receivables, net	`IncreaseDecreaseInReceivables`	$59.38M	USD	Annual
Prepaid expense and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.92M	USD	Annual
Prepaid expense and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$5.08M	USD	Annual
Prepaid expense and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$16.62M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-3.93M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.98M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$205.00K	USD	Annual
Medical claims and related payables	`IncreaseDecreaseInMedicalClaimsAndRelatedPayables`	$-42.38M	USD	Annual
Medical claims and related payables	`IncreaseDecreaseInMedicalClaimsAndRelatedPayables`	$-107.71M	USD	Annual
Medical claims and related payables	`IncreaseDecreaseInMedicalClaimsAndRelatedPayables`	$-76.34M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$19.36M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$24.92M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$65.74M	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$5.61M	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-11.89M	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.70M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-53.20M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-148.16M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-130.81M	USD	Annual
Purchase of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$15.43M	USD	Annual
Purchase of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.77M	USD	Annual
Purchase of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$6.56M	USD	Annual
Purchase of intangible assets, net	`PaymentsToAcquireIntangibleAssets`	$6.86M	USD	Annual
Purchase of intangible assets, net	`PaymentsToAcquireIntangibleAssets`	$575.00K	USD	Annual
Purchase of intangible assets, net	`PaymentsToAcquireIntangibleAssets`	$17.23M	USD	Annual
Investments in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$6.51M	USD	Annual
Investments in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$82.83M	USD	Annual
Investments in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$3.85M	USD	Annual
Investments in marketable securities	`PaymentsToAcquireMarketableSecurities`	$458.26M	USD	Annual
Investments in marketable securities	`PaymentsToAcquireMarketableSecurities`	-	USD	Annual
Investments in marketable securities	`PaymentsToAcquireMarketableSecurities`	-	USD	Annual
Proceeds from maturities and sales of marketable securities and other	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$52.55M	USD	Annual
Proceeds from maturities and sales of marketable securities and other	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$7.09M	USD	Annual
Proceeds from maturities and sales of marketable securities and other	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.06M	USD	Annual
Proceeds from sale of business and property, net of cash divested	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$26.20M	USD	Annual
Proceeds from sale of business and property, net of cash divested	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$-1.34M	USD	Annual
Proceeds from sale of business and property, net of cash divested	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$500.00K	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$22.07M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-444.39M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-90.51M	USD	Annual
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	Annual
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	$1.17B	USD	Annual
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	Annual
Proceeds from equity issuances, net	`ProceedsFromIssuanceOfCommonStock`	$33.06M	USD	Annual
Proceeds from equity issuances, net	`ProceedsFromIssuanceOfCommonStock`	$34.40M	USD	Annual
Proceeds from equity issuances, net	`ProceedsFromIssuanceOfCommonStock`	$18.09M	USD	Annual
Repurchase of shares, net	`PaymentsForRepurchaseOfEquity`	-	USD	Annual
Repurchase of shares, net	`PaymentsForRepurchaseOfEquity`	-	USD	Annual
Repurchase of shares, net	`PaymentsForRepurchaseOfEquity`	$6.74M	USD	Annual
Proceeds from the issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$100.00M	USD	Annual
Proceeds from the issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	Annual
Proceeds from the issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	Annual
Repayments of long-term borrowings and other	`RepaymentsOfLongTermDebt`	$5.00M	USD	Annual
Repayments of long-term borrowings and other	`RepaymentsOfLongTermDebt`	$119.90M	USD	Annual
Repayments of long-term borrowings and other	`RepaymentsOfLongTermDebt`	$3.04M	USD	Annual
Equity and debt issuance costs and other	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Equity and debt issuance costs and other	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Equity and debt issuance costs and other	`PaymentsOfDebtIssuanceCosts`	$14.74M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$28.06M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.15B	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$24.62M	USD	Annual
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-547.14M	USD	Annual
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$915.73M	USD	Annual
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-6.52M	USD	Annual
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$135.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$139.15M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$507.68M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	-	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	-	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$6.46M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$3.92M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.05B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$507.68M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$145.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$139.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$135.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$139.15M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$507.68M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	-	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	-	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$6.46M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$3.92M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.05B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$507.68M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$145.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$139.09M	USD	Point-in-time

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.04B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-232.03M	USD	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	400.10M	shares	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	412.38M	shares	Point-in-time
Net income (loss)	`ProfitLoss`	$-406.79M	USD	Annual
Net income (loss)	`ProfitLoss`	$-106.86M	USD	Annual
Net income (loss)	`ProfitLoss`	$-60.05M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-5.56M	USD	Annual
Reclassification of contingently redeemable common stock in connection with IPO, value	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$309.50M	USD	Annual
Issuance of common stock, shares	`StockIssuedDuringPeriodSharesNewIssues`	11.70M	shares	Point-in-time
Issuance of common stock, shares	`StockIssuedDuringPeriodSharesNewIssues`	1.20M	shares	Annual
Issuance of common stock, value	`StockIssuedDuringPeriodValueNewIssues`	$1.16B	USD	Annual
Issuance of common stock under partner physician group equity agreements upon IPO, value	`IssuanceOfCommonStockValueUnderPartnersEquityAgreement`	$268.47M	USD	Annual
Issuance of contingently redeemable common stock	`IssuanceOfContingentlyRedeemableCommonStockValue`	$-460.00K	USD	Annual
Issuance of common stock	`StockIssuedDuringPeriodValueIssuedForServices`	$1.50M	USD	Point-in-time
Issuance of common stock	`StockIssuedDuringPeriodValueIssuedForServices`	$5.55M	USD	Annual
Settlement of stock-based liabilities	`AdjustmentsToAdditionalPaidInCapitalSettlementOfStockBasedLiabilities`	$1.50M	USD	Annual
Shares withheld related to net share settlement, amount	`SharesWithheldRelatedToNetShareSettlementAmount`	$-831.00K	USD	Annual
Repurchase of common stock	`StockRepurchasedDuringPeriodValue`	$6.74M	USD	Annual
Repurchase of common stock, shares	`StockRepurchasedDuringPeriodShares`	1.50M	shares	Annual
Exercises and vesting of stock-based awards	`StockIssuedDuringPeriodValueStockOptionsExercised`	$33.89M	USD	Annual
Exercises and vesting of stock-based awards	`StockIssuedDuringPeriodValueStockOptionsExercised`	$18.09M	USD	Annual
Exercises and vesting of stock-based awards	`StockIssuedDuringPeriodValueStockOptionsExercised`	$814.00K	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$23.93M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$28.38M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.69M	USD	Annual
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.04B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-232.03M	USD	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	400.10M	shares	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	412.38M	shares	Point-in-time

Comprehensive Income 15 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-406.79M	USD	Annual
Net income (loss)	`ProfitLoss`	$-106.86M	USD	Annual
Net income (loss)	`ProfitLoss`	$-60.05M	USD	Annual
Net unrealized gain (loss) on marketable debt securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTaxes`	-	USD	Annual
Net unrealized gain (loss) on marketable debt securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTaxes`	-	USD	Annual
Net unrealized gain (loss) on marketable debt securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTaxes`	$-5.56M	USD	Annual
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-406.79M	USD	Annual
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-60.05M	USD	Annual
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-112.42M	USD	Annual
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-300.00K	USD	Annual
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	Annual
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-311.00K	USD	Annual
Total comprehensive income (loss) attributable to agilon health, inc.	`ComprehensiveIncomeNetOfTax`	$-406.49M	USD	Annual
Total comprehensive income (loss) attributable to agilon health, inc.	`ComprehensiveIncomeNetOfTax`	$-60.05M	USD	Annual
Total comprehensive income (loss) attributable to agilon health, inc.	`ComprehensiveIncomeNetOfTax`	$-112.11M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.